ML 239 - DEV 4 | CID 49843203

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2871

CAS [1378872-36-6]

MF C13H10Cl3N3O2
MW 346.60

Purity: 98%
Soluble in DMSO

ML 239

Description

ML 239 is a selective inhibitor of breast cancer stem cells (IC50 value of 1.16 µM). Displayed greater than 23-fold selective inhibition of the breast cancer stem cells-like cell line over the isogenic control cell line.

KEYWORDS: ML 239 | supplier | BCSC inhibitor | DEV 4 | CID 49843203 | ML239 | ML-239 | DEV4 | DEV-4 | CID49843203 | CAS [1378872-36-6] | Stem cells (iPSC) | Inhibitor | Breast Cancer Stem Cells | CAS [1426575-84-9]

L Carmody et al. Identification of a Selective Small-Molecule Inhibitor of Breast Cancer Stem Cells - Probe 1. Probe Reports from the NIH Molecular Libraries Program. 2010-2011.

AR Germain et al. Identification of a selective small molecule inhibitor of breast cancer stem cells. Bioorg Med Chem Lett. 2012 May 15;22(10):3571-4.

Selective inhibitor of breast cancer stem cells

Chemical name

(E)-N'-((1H-Pyrrol-2-yl)methylene)-2-(2,4,6-trichlorophenoxy)acetohydrazide

Parent CAS No.

[1378872-36-6]

Order

Size	Unit Price	Stock
10 mg	€95.00	In Stock
50 mg	€345.00	In Stock

Special Offers

Size	Unit Price	Stock
2 x 10 mg	€140.00	In Stock

Need more? Bulk Inquiry

Customer Support

Customer Services

About Axon Medchem

Contact Us

ML 239 - DEV 4 | CID 49843203

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

ML 239 - DEV 4 | CID 49843203

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us